US Stock MarketDetailed Quotes

ROSGQ Rosetta Genomics Ltd

Watchlist

0.000100
0.0000000.00%

15min DelayClose Jul 9 09:30 ET

592.99Market Cap0.00P/E (TTM)

Rosetta Genomics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2016

(FY)Dec 31, 2015

(FY)Dec 31, 2014

(FY)Dec 31, 2013

(FY)Dec 31, 2012

(FY)Dec 31, 2011

(FY)Dec 31, 2010

(FY)Dec 31, 2009

(FY)Dec 31, 2008

(FY)Dec 31, 2007

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

38.78%-10.37M

-24.49%-16.93M

-21.09%-13.6M

-29.61%-11.23M

13.65%-8.67M

28.25%-10.04M

-14.39%-13.99M

-2.69%-12.23M

-47.64%-11.91M

-25.76%-8.07M

Net income from continuing operations

6.41%-16.23M

-19.41%-17.35M

-10.30%-14.53M

-23.13%-13.17M

-44.02%-10.7M

47.76%-7.43M

3.63%-14.22M

-71.10%-14.75M

41.19%-8.62M

-92.73%-14.66M

Operating gains losses

----

113.64%6K

-183.02%-44K

104.48%53K

-6,131.58%-1.18M

99.67%-19K

-142,925.00%-5.71M

102.80%4K

Depreciation and amortization

20.86%904K

150.17%748K

0.34%299K

8.76%298K

-40.17%274K

10.36%458K

20.64%415K

8.86%344K

76.54%316K

-20.09%179K

Other non cash items

-65.38%558K

2,140.51%1.61M

-43.64%-79K

---55K

----

-1,669.52%-1.65M

337.50%105K

-63.08%24K

-98.90%65K

436.61%5.89M

Change In working capital

226.20%3.55M

-1,075.31%-2.81M

-130.06%-239K

367.68%795K

85.70%-297K

-1,638.52%-2.08M

-83.17%135K

68.49%802K

-8.46%476K

3,614.29%520K

-Change in receivables

187.77%2.6M

-942.61%-2.96M

-330.89%-284K

134.75%123K

-500.00%-354K

-154.63%-59K

112.84%108K

-12,114.29%-841K

108.75%7K

-21.21%-80K

-Change in payables and accrued expense

522.37%946K

-44.32%152K

-59.38%273K

216.26%672K

71.36%-578K

-216.85%-2.02M

3,129.82%1.73M

-112.15%-57K

-21.83%469K

650.00%600K

-Change in other working capital

----

---228K

----

--635K

----

-200.00%-1.7M

--1.7M

----

Cash from discontinued investing activities

1,983.33%625K

102.45%30K

-556.72%-1.22M

-41.48%268K

1,861.54%458K

-26K

Operating cash flow

38.78%-10.37M

-24.49%-16.93M

-28.22%-13.6M

-22.82%-10.61M

23.30%-8.64M

17.93%-11.26M

-16.57%-13.72M

1.37%-11.77M

-47.97%-11.94M

-25.76%-8.07M

Investing cash flow

Cash flow from continuing investing activities

-80.08%823K

1,701.16%4.13M

96.84%-258K

-3,523.56%-8.15M

-119.40%-225K

-81.16%1.16M

219.64%6.16M

-138.22%-5.15M

224.19%13.47M

-93.68%-10.84M

Net PPE purchase and sale

18.32%-223K

-10.53%-273K

60.54%-247K

-198.10%-626K

-233.76%-210K

137.56%157K

-111.11%-418K

54.06%-198K

39.64%-431K

-210.43%-714K

Net business purchase and sale

--0

---2.12M

--0

----

450.00%814K

522.86%148K

---35K

--0

----

Net investment purchase and sale

----

-93.83%148K

208.79%2.4M

-114.45%-2.21M

250.68%15.26M

-88.68%-10.13M

Net other investing changes

-83.97%1.05M

59,427.27%6.53M

99.85%-11K

-50,080.00%-7.53M

-136.59%-15K

-98.98%41K

248.74%4.03M

-98.24%-2.71M

---1.37M

----

Cash from discontinued investing activities

Investing cash flow

-80.08%823K

1,701.16%4.13M

96.84%-258K

-3,523.56%-8.15M

91.10%-225K

-141.14%-2.53M

219.07%6.14M

-145.45%-5.16M

204.68%11.35M

-93.68%-10.84M

Financing cash flow

Cash flow from continuing financing activities

-81.18%3.26M

245.36%17.32M

5.87%5.02M

-87.83%4.74M

306.99%38.93M

37.10%9.56M

8.59%6.98M

724.65%6.42M

-97.14%779K

121.29%27.27M

Net issuance payments of debt

---28K

--0

----

488.57%272K

48.91%-70K

-119.74%-137K

-6.97%694K

957.47%746K

51.40%-87K

Net common stock issuance

----

-87.74%4.74M

301.21%38.65M

35.44%9.63M

24.14%7.11M

--5.73M

----

98.64%27.36M

Proceeds from stock option exercised by employees

-81.02%3.29M

245.36%17.32M

--5.02M

----

--0

--33K

----

Cash from discontinued financing activities

2.23M

-4.00%24K

25K

Financing cash flow

-81.18%3.26M

245.36%17.32M

5.87%5.02M

-87.83%4.74M

229.98%38.93M

69.09%11.8M

8.19%6.98M

701.99%6.45M

-97.05%804K

121.29%27.27M

Net cash flow

Beginning cash position

56.98%12.45M

-52.73%7.93M

-45.54%16.77M

4,090.20%30.8M

-73.05%735K

-18.08%2.73M

-75.90%3.33M

1.63%13.81M

159.95%13.59M

6.32%5.23M

Current changes in cash

-239.09%-6.28M

151.08%4.52M

36.93%-8.85M

-146.65%-14.02M

1,609.19%30.06M

-230.90%-1.99M

94.26%-602K

-4,842.99%-10.48M

-97.36%221K

2,588.75%8.36M

End cash Position

-50.49%6.16M

56.98%12.45M

-52.73%7.93M

-45.54%16.77M

4,090.20%30.8M

-73.05%735K

-18.08%2.73M

-75.90%3.33M

1.63%13.81M

159.95%13.59M

Free cash flow

38.45%-10.59M

-24.24%-17.21M

-23.28%-13.85M

-26.13%-11.23M

20.98%-8.91M

20.32%-11.27M

-18.18%-14.15M

3.20%-11.97M

-40.84%-12.37M

-32.11%-8.78M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2016	(FY)Dec 31, 2015	(FY)Dec 31, 2014	(FY)Dec 31, 2013	(FY)Dec 31, 2012	(FY)Dec 31, 2011	(FY)Dec 31, 2010	(FY)Dec 31, 2009	(FY)Dec 31, 2008	(FY)Dec 31, 2007
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	38.78%-10.37M	-24.49%-16.93M	-21.09%-13.6M	-29.61%-11.23M	13.65%-8.67M	28.25%-10.04M	-14.39%-13.99M	-2.69%-12.23M	-47.64%-11.91M	-25.76%-8.07M
Net income from continuing operations	6.41%-16.23M	-19.41%-17.35M	-10.30%-14.53M	-23.13%-13.17M	-44.02%-10.7M	47.76%-7.43M	3.63%-14.22M	-71.10%-14.75M	41.19%-8.62M	-92.73%-14.66M
Operating gains losses	----	----	----	113.64%6K	-183.02%-44K	104.48%53K	-6,131.58%-1.18M	99.67%-19K	-142,925.00%-5.71M	102.80%4K
Depreciation and amortization	20.86%904K	150.17%748K	0.34%299K	8.76%298K	-40.17%274K	10.36%458K	20.64%415K	8.86%344K	76.54%316K	-20.09%179K
Other non cash items	-65.38%558K	2,140.51%1.61M	-43.64%-79K	---55K	----	-1,669.52%-1.65M	337.50%105K	-63.08%24K	-98.90%65K	436.61%5.89M
Change In working capital	226.20%3.55M	-1,075.31%-2.81M	-130.06%-239K	367.68%795K	85.70%-297K	-1,638.52%-2.08M	-83.17%135K	68.49%802K	-8.46%476K	3,614.29%520K
-Change in receivables	187.77%2.6M	-942.61%-2.96M	-330.89%-284K	134.75%123K	-500.00%-354K	-154.63%-59K	112.84%108K	-12,114.29%-841K	108.75%7K	-21.21%-80K
-Change in payables and accrued expense	522.37%946K	-44.32%152K	-59.38%273K	216.26%672K	71.36%-578K	-216.85%-2.02M	3,129.82%1.73M	-112.15%-57K	-21.83%469K	650.00%600K
-Change in other working capital	----	----	---228K	----	--635K	----	-200.00%-1.7M	--1.7M	----	----
Cash from discontinued investing activities				1,983.33%625K	102.45%30K	-556.72%-1.22M	-41.48%268K	1,861.54%458K	-26K
Operating cash flow	38.78%-10.37M	-24.49%-16.93M	-28.22%-13.6M	-22.82%-10.61M	23.30%-8.64M	17.93%-11.26M	-16.57%-13.72M	1.37%-11.77M	-47.97%-11.94M	-25.76%-8.07M
Investing cash flow
Cash flow from continuing investing activities	-80.08%823K	1,701.16%4.13M	96.84%-258K	-3,523.56%-8.15M	-119.40%-225K	-81.16%1.16M	219.64%6.16M	-138.22%-5.15M	224.19%13.47M	-93.68%-10.84M
Net PPE purchase and sale	18.32%-223K	-10.53%-273K	60.54%-247K	-198.10%-626K	-233.76%-210K	137.56%157K	-111.11%-418K	54.06%-198K	39.64%-431K	-210.43%-714K
Net business purchase and sale	--0	---2.12M	--0	----	----	450.00%814K	522.86%148K	---35K	--0	----
Net investment purchase and sale	----	----	----	----	----	-93.83%148K	208.79%2.4M	-114.45%-2.21M	250.68%15.26M	-88.68%-10.13M
Net other investing changes	-83.97%1.05M	59,427.27%6.53M	99.85%-11K	-50,080.00%-7.53M	-136.59%-15K	-98.98%41K	248.74%4.03M	-98.24%-2.71M	---1.37M	----
Cash from discontinued investing activities
Investing cash flow	-80.08%823K	1,701.16%4.13M	96.84%-258K	-3,523.56%-8.15M	91.10%-225K	-141.14%-2.53M	219.07%6.14M	-145.45%-5.16M	204.68%11.35M	-93.68%-10.84M
Financing cash flow
Cash flow from continuing financing activities	-81.18%3.26M	245.36%17.32M	5.87%5.02M	-87.83%4.74M	306.99%38.93M	37.10%9.56M	8.59%6.98M	724.65%6.42M	-97.14%779K	121.29%27.27M
Net issuance payments of debt	---28K	--0	----	----	488.57%272K	48.91%-70K	-119.74%-137K	-6.97%694K	957.47%746K	51.40%-87K
Net common stock issuance	----	----	----	-87.74%4.74M	301.21%38.65M	35.44%9.63M	24.14%7.11M	--5.73M	----	98.64%27.36M
Proceeds from stock option exercised by employees	-81.02%3.29M	245.36%17.32M	--5.02M	----	----	----	----	--0	--33K	----
Cash from discontinued financing activities						2.23M	0	-4.00%24K	25K
Financing cash flow	-81.18%3.26M	245.36%17.32M	5.87%5.02M	-87.83%4.74M	229.98%38.93M	69.09%11.8M	8.19%6.98M	701.99%6.45M	-97.05%804K	121.29%27.27M
Net cash flow
Beginning cash position	56.98%12.45M	-52.73%7.93M	-45.54%16.77M	4,090.20%30.8M	-73.05%735K	-18.08%2.73M	-75.90%3.33M	1.63%13.81M	159.95%13.59M	6.32%5.23M
Current changes in cash	-239.09%-6.28M	151.08%4.52M	36.93%-8.85M	-146.65%-14.02M	1,609.19%30.06M	-230.90%-1.99M	94.26%-602K	-4,842.99%-10.48M	-97.36%221K	2,588.75%8.36M
End cash Position	-50.49%6.16M	56.98%12.45M	-52.73%7.93M	-45.54%16.77M	4,090.20%30.8M	-73.05%735K	-18.08%2.73M	-75.90%3.33M	1.63%13.81M	159.95%13.59M
Free cash flow	38.45%-10.59M	-24.24%-17.21M	-23.28%-13.85M	-26.13%-11.23M	20.98%-8.91M	20.32%-11.27M	-18.18%-14.15M	3.20%-11.97M	-40.84%-12.37M	-32.11%-8.78M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	--	Unqualified Opinion	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall